Evidence map›Paper›PMID 41394839›Full record

ArticleFrontiers in immunology2025

Case Report: Anti-SOX1 antibody-associated limbic encephalitis with hippocampal sclerosis: the first autopsy case.

Rina Izumi, Koji Hayashi, Ei Kawahara, Yasuo Miki, Koichi Wakabayashi, Asuka Suzuki, Yuka Nakaya, Naoko Takaku, Mamiko Sato, Yusuke Horiuchi and 4 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  2. Paraneoplastic neurologic syndrome in a 65-year-old woman with small cell lung cancer.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rina Izumi *Department of Rehabilitation Medicine, Fukui General Hospital, Fukui, Japan.
Koji Hayashi *Department of Rehabilitation Medicine, Fukui General Hospital, Fukui, Japan.
Ei KawaharaDepartment of Pathology, Fukui General Hospital, Fukui, Japan.
Yasuo MikiDepartment of Neuropathology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Koichi WakabayashiDepartment of Neuropathology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Asuka SuzukiDepartment of Rehabilitation Medicine, Fukui General Hospital, Fukui, Japan.
Yuka NakayaDepartment of Rehabilitation Medicine, Fukui General Hospital, Fukui, Japan.
Naoko TakakuDepartment of Rehabilitation Medicine, Fukui General Hospital, Fukui, Japan.
Mamiko SatoDepartment of Rehabilitation Medicine, Fukui General Hospital, Fukui, Japan.
Yusuke HoriuchiDepartment of Neurology, University of Fukui, Fukui, Japan.
Soichi EnomotoDepartment of Neurology, University of Fukui, Fukui, Japan.
Yuki KitazakiDepartment of Neurology, University of Fukui, Fukui, Japan.
Tadanori HamanoDepartment of Neurology, University of Fukui, Fukui, Japan.
Yasutaka KobayashiGraduate School of Health Science, Fukui University of Medical Science, Fukui, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first autopsy case of anti-SOX1 antibody-associated encephalitis accompanied by hippocampal sclerosis (HS). The patient was a 69-year-old man with a long-standing history of schizophrenia who presented with generalized seizures, fever, and altered mental status. Despite treatment for pneumonia and hyponatremia, his condition rapidly deteriorated, resulting in recurrent seizures and impaired consciousness. Imaging and cerebrospinal fluid analysis confirmed paraneoplastic limbic encephalitis associated with small-cell lung carcinoma (SCLC), and serum analysis revealed strongly positive anti-SOX1 antibodies. Following multidisciplinary interventions, palliative care was initiated, and the patient passed away on day 115. Autopsy findings included a densely proliferating SCLC in the right lung, confirming the paraneoplastic etiology. Neuropathologically, the hippocampus showed profound neuronal loss and astrogliosis primarily affecting the CA1, CA3, and dentate gyrus regions, consistent with HS. Histological analysis of the dentate gyri revealed granule cell dispersion and gliosis in the granular and molecular layers. Notably, the neuronal loss exhibited a non-classic HS pattern, distinguishing the acute pathology from typical chronic changes seen in mesial temporal lobe epilepsy or long-standing schizophrenia. CD8-positive cytotoxic T lymphocytes (CTLs) infiltrated extensively throughout the central nervous system and were particularly prominent in the hippocampus, demonstrating a T cell-mediated cytotoxic mechanism for neuronal destruction. The presence of MHC class I antigen positivity on residual neurons further supported this immune-mediated neuronal destruction. Additionally, CD8-positive CTL infiltration was observed in the sciatic nerve and mild atrophy was noted in the psoas muscle, underscoring a generalized paraneoplastic process affecting multiple tissues. These findings provide the first mechanistic pathological evidence for anti-SOX1 antibody-associated encephalitis, illustrating that neuronal destruction is driven by CD8+ CTL cytotoxicity. The case underscores the complex pathological interactions between acute autoimmune responses and pre-existing psychiatric conditions, expanding our understanding of the neuropathological spectrum of paraneoplastic limbic encephalitis associated with SCLC.

Indexed as

AutoantibodiesHippocampusLimbic EncephalitisSOXB1 Transcription FactorsAgedAutopsyFatal OutcomeHippocampal SclerosisHumansLung NeoplasmsMaleSclerosisAutoantibodiesSOX1 protein, humanSOXB1 Transcription Factorsanti-SOX1 antibodiesepilepsyhippocampal sclerosislimbic encephalitisparaneoplasticsmall-cell lung carcinomaSry-like high mobility group box 1

Identifiers

PMID41394839
PMCPMC12696179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.